Abstract
Twenty-five evaluable patients with advanced non-squamous carcinoma of the uterine cervix were treated with mitoxantrone 12 mg/m2 every three weeks. All patients had good performance status and measurable disease and only 11 had received prior chemotherapy. One complete and one partial response were noted among 15 patients with no prior chemotherapy while no responses were seen in 11 previously treated patients. The major toxicity was myelosuppression; other toxicity was mild. The median progression-free interval was 2.1 months and median survival 4.3 months. Mitoxantrone displays minimal activity in patients with advanced non-squamous carcinoma of the cervix.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bonomi PD, Yordan Jr EL: Chemotherapy of cervical carcinoma. In: GDeppe (ed) Chemotherapy of Gynecologic Cancer. Alan R Liss, Inc. NY, pp 103–124, 1984
Paciucci PA, Ohnuma T, Cuttner J, Silver RT, Holland JF: Mitoxantrone in patients with acute leukemia in relapse. Cancer Res 43:3919–3922, 1983
Smith IE: Mitoxantrone (novantrone): A review of experimental and early clinical studies. Cancer Treat Rev 10:103–115, 1983
Stuart-Harris RC, Smith IE: Mitoxantrone: A phase II study in the treatment of patients with advanced breast carcinoma and other solid tumors. Cancer Chemother Pharmacol 8:179–182, 1982
Yap HY, Blumenschein GR, Schell FC, Buzdar AU, Valdivieso M, Bodey GP: Dihydroxyanthracenedione: A promising new drug in the treatment of metastatic breast cancer. Ann Intern Med 95:694–697, 1981
Smith IE: Mitoxantrone (novantrone): a review of experimental and early clinical studies. Cancer Treat Rev 10:103–115, 1983
Thigpen T, Shingleton H, Homesley H, Lagasse L and Blesing J: Cis-Platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix. Cancer 48:899–903, 1981
Muss HB, Sutton GP, Bundy B, Hatch KD: Mitoxantrone (NSC 301739) in patients with advanced cervical carcinoma: A phase II study of the Gynecologic Oncology Group, Am J Clin Oncol (CCT) 8:312–315, 1985
Hilgers RD, VonHoff DD, Stephens RL, Boutselis JG: Mitoxantrone and advanced squamous cell carcinoma of the cervix: A Southwest Oncology Group Study. Cancer Treat Rep 70:527–528, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Muss, H.B., Bundy, B.N., Homesley, H.D. et al. Mitoxantrone in the treatment of advanced non-squamous carcinoma of the cervix (A phase II trial of the gynecologic oncology group). Invest New Drugs 5, 199–202 (1987). https://doi.org/10.1007/BF00203546
Issue Date:
DOI: https://doi.org/10.1007/BF00203546